S3846 Gene test beta-thalassemia
Also known as: beta-thalassemia testing, thalassemia gene test
Genetic testing for mutations in the HBB gene causing beta-thalassemia, a hemoglobin disorder affecting red blood cell production and oxygen transport.
In Plain Language
genetic test for blood disorder; inherited anemia gene test
Clinical Context
Used in hematology for diagnosis of beta-thalassemia trait and disease in patients with microcytic anemia and hemolytic symptoms.
RVU Information
CPT S3846 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
S-codes are used by private payers (not Medicare) for services without a standard CPT or HCPCS code. Coverage varies significantly between insurers. Verify payer acceptance before billing and document medical necessity thoroughly.
Specialties
Frequently Asked Questions
What is CPT code S3846?
CPT S3846 (Gene test beta-thalassemia) is a S Codes code. Genetic testing for mutations in the HBB gene causing beta-thalassemia, a hemoglobin disorder affecting red blood cell production and oxygen transport.
Is S3846 covered by insurance?
S3846 is a temporary HCPCS code. Coverage varies by payer and may change when permanent codes are assigned. Used in hematology for diagnosis of beta-thalassemia trait and disease in patients with microcytic anemia and hemolytic symptoms.
When is CPT S3846 used?
Used in hematology for diagnosis of beta-thalassemia trait and disease in patients with microcytic anemia and hemolytic symptoms.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against national data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.